Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Mikhail

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Mayo Clinic Proceedings|March 13, 2003
Low-dose hormone replacement therapy for hot flashesNasser Mikhail
Archives of Internal Medicine|October 13, 2004
Efficacy and safety of sildenafil in patients with congestive heart failureNasser Mikhail
Current Hypertension Reports|March 13, 2009
The metabolic syndrome: insulin resistanceNasser Mikhail
Current Drug Safety|March 20, 2012
Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetesNasser Mikhail
Southern Medical Journal|November 17, 2010
Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapyNasser Mikhail
Lancet (London, England)|January 30, 2007
GliptinsNasser Mikhail
Annals of Internal Medicine|November 3, 2004
Rosiglitazone for treatment of HIV lipodystrophyNasser Mikhail
Expert Opinion on Investigational Drugs|August 20, 2015
Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitusNasser Mikhail
Current Drug Safety|August 31, 2016
Safety of Technosphere Inhaled InsulinNasser Mikhail
Current Hypertension Reports|March 19, 2003
Insulin resistance in HIV-related lipodystrophyNasser Mikhail
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Mayo Clinic Proceedings|March 13, 2003
Low-dose hormone replacement therapy for hot flashesNasser Mikhail
Archives of Internal Medicine|October 13, 2004
Efficacy and safety of sildenafil in patients with congestive heart failureNasser Mikhail
Current Hypertension Reports|March 13, 2009
The metabolic syndrome: insulin resistanceNasser Mikhail
Current Drug Safety|March 20, 2012
Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetesNasser Mikhail
Southern Medical Journal|November 17, 2010
Clinical significance of vitamin D deficiency in primary hyperparathyroidism, and safety of vitamin D therapyNasser Mikhail
Lancet (London, England)|January 30, 2007
GliptinsNasser Mikhail
Annals of Internal Medicine|November 3, 2004
Rosiglitazone for treatment of HIV lipodystrophyNasser Mikhail
Expert Opinion on Investigational Drugs|August 20, 2015
Remogliflozin etabonate: a novel SGLT2 inhibitor for treatment of diabetes mellitusNasser Mikhail
Current Drug Safety|August 31, 2016
Safety of Technosphere Inhaled InsulinNasser Mikhail
Current Hypertension Reports|March 19, 2003
Insulin resistance in HIV-related lipodystrophyNasser Mikhail
Pageof 6